KH
MCID: KPS002
MIFTS: 39

Kaposiform Hemangioendothelioma (KH)

Categories: Blood diseases, Cancer diseases, Cardiovascular diseases, Fetal diseases, Rare diseases
Data Licensing
For inquiries, contact:

Aliases & Classifications for Kaposiform Hemangioendothelioma

MalaCards integrated aliases for Kaposiform Hemangioendothelioma:

Name: Kaposiform Hemangioendothelioma 19 58 75 28 5 71 75
Congenital Cutaneous Multifocal Kaposiform Hemangioendothelioma 19
Kaposiform Hemangio-Endothelioma 19
Khe 19
Kh 19

Characteristics:


Age Of Onset:

All ages 58

Classifications:

Orphanet: 58  
Rare circulatory system diseases
Developmental anomalies during embryogenesis


External Ids:

MESH via Orphanet 44 C537007
ICD10 via Orphanet 32 C49.9
UMLS via Orphanet 72 C1367420
Orphanet 58 ORPHA2122
UMLS 71 C1367420

Summaries for Kaposiform Hemangioendothelioma

GARD: 19 A rare low-grade malignant cutaneous or visceral vascular tumour that may be associated with severe thrombopaenia with consumption coagulopathy (Kasabach-Merritt syndrome) in pediatric patients.

MalaCards based summary: Kaposiform Hemangioendothelioma, also known as congenital cutaneous multifocal kaposiform hemangioendothelioma, is related to hemangioma-thrombocytopenia syndrome and angioma, tufted. An important gene associated with Kaposiform Hemangioendothelioma is GNA14 (G Protein Subunit Alpha 14). The drugs Miconazole and Sirolimus have been mentioned in the context of this disorder. Affiliated tissues include endothelial, lymph node and bone.

Orphanet: 58 A rare low-grade malignant cutaneous or visceral vascular tumour that may be associated with severe thrombopaenia with consumption coagulopathy (Kasabach-Merritt syndrome) in pediatric patients.

Wikipedia: 75 A vascular tumor is a tumor of vascular origin; a soft tissue growth that can be either benign or... more...

Related Diseases for Kaposiform Hemangioendothelioma

Diseases related to Kaposiform Hemangioendothelioma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 100)
# Related Disease Score Top Affiliating Genes
1 hemangioma-thrombocytopenia syndrome 11.5
2 angioma, tufted 11.4
3 hemangioendothelioma 11.2
4 hemangioma 10.8
5 kaposi sarcoma 10.8
6 rare vascular tumor 10.7
7 capillary hemangioma 10.7
8 vascular cancer 10.7
9 thrombocytopenia 10.7
10 lymphangiomatosis 10.6
11 lymphangioma 10.4
12 disseminated intravascular coagulation 10.4
13 rare tumor 10.4
14 human herpesvirus 8 10.4
15 hereditary lymphedema i 10.4
16 rare lymphatic malformation 10.4
17 factor viii deficiency 10.3
18 cholestasis 10.3
19 obstructive jaundice 10.3
20 intestinal obstruction 10.3
21 scoliosis 10.3
22 spindle cell hemangioma 10.3
23 hemolytic anemia 10.3
24 pyogenic granuloma 10.3
25 congenital hemangioma 10.3
26 hydrops fetalis, nonimmune 10.2
27 thrombotic thrombocytopenic purpura, hereditary 10.2
28 short stature, onychodysplasia, facial dysmorphism, and hypotrichosis 10.2
29 rapidly involuting congenital hemangioma 10.2
30 respiratory failure 10.2
31 pneumocystosis 10.2
32 purpura 10.2
33 non-involuting congenital hemangioma 10.2
34 coloboma of optic nerve 10.0
35 hypercalcemia, infantile, 1 10.0
36 intussusception 10.0
37 laryngomalacia 10.0
38 lymphatic malformation 1 10.0
39 neurofibromatosis, type i 10.0
40 tuberous sclerosis 1 10.0
41 volvulus of midgut 10.0
42 camptodactyly-arthropathy-coxa vara-pericarditis syndrome 10.0
43 ascites, chylous 10.0
44 hemangiopericytoma, malignant 10.0
45 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 10.0
46 immune deficiency disease 10.0
47 neurodegeneration with brain iron accumulation 2a 10.0
48 pancreatic cancer 10.0
49 ataxia with vitamin e deficiency 10.0
50 neurofibromatosis-noonan syndrome 10.0

Graphical network of the top 20 diseases related to Kaposiform Hemangioendothelioma:



Diseases related to Kaposiform Hemangioendothelioma

Symptoms & Phenotypes for Kaposiform Hemangioendothelioma

Drugs & Therapeutics for Kaposiform Hemangioendothelioma

Drugs for Kaposiform Hemangioendothelioma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 36)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Miconazole Approved, Investigational, Vet_approved Phase 4 22916-47-8 4189
2
Sirolimus Approved, Investigational Phase 4 53123-88-9 5284616 6436030
3
Clotrimazole Approved, Vet_approved Phase 4 23593-75-1 2812
4
Benzocaine Approved, Investigational Phase 4 1994-09-7, 94-09-7 2337
5
Tannic acid Approved Phase 4 1401-55-4 16129878 16129778
6
Tacrolimus Approved, Investigational Phase 4 104987-11-3 6473866 445643
7 Anti-Infective Agents Phase 4
8 Antifungal Agents Phase 4
9 Immunosuppressive Agents Phase 4
10 Antibiotics, Antitubercular Phase 4
11 Anti-Bacterial Agents Phase 4
12 Immunologic Factors Phase 4
13 Calcineurin Inhibitors Phase 4
14 Pharmaceutical Solutions Phase 4
15
Prednisolone phosphate Approved, Vet_approved Phase 2 302-25-0
16
Prednisolone acetate Approved, Vet_approved Phase 2 52-21-1
17
Prednisolone Approved, Vet_approved Phase 2 50-24-8 4894 5755
18
Methylprednisolone hemisuccinate Approved Phase 2 2921-57-5 1875
19
Methylprednisolone Approved, Vet_approved Phase 2 83-43-2 4159 6741
20
Vincristine Approved, Investigational Phase 2 2068-78-2, 57-22-7 5978
21
Prednisolone hemisuccinate Experimental Phase 2 2920-86-7 4897
22
Methylprednisolone Acetate Phase 2 584547
23 Hormones Phase 2
24 glucocorticoids Phase 2
25 Antineoplastic Agents, Hormonal Phase 2
26 Hormone Antagonists Phase 2
27 Anti-Inflammatory Agents Phase 2
28 Tubulin Modulators Phase 2
29 Antimitotic Agents Phase 2
30
Prednisone Approved, Vet_approved Phase 1 53-03-2 5865
31 Vaccines
32 Antibodies
33 Immunoglobulins, Intravenous
34 Immunoglobulins
35 Mitogens
36 Endothelial Growth Factors

Interventional clinical trials:

(show all 12)
# Name Status NCT ID Phase Drugs
1 Tacrolimus for the Treatment of Superficial Kaposiform Hemangioendothelioma and Tufted Angioma: a Single Arm Prospective Study Recruiting NCT04056962 Phase 4 Tacrolimus ointment
2 Guided Discontinuation Versus Maintenance Treatment of Sirolimus in Pediatric Patients With Kaposiform Hemangioendothelioma: a Randomized Controlled Trial Recruiting NCT04448873 Phase 4 Sirolimus
3 Safety and Efficacy of Low-dose Sirolimus to Kaposiform Hemangioendothelioma:A Prospective, Randomized Open Trial Recruiting NCT04077515 Phase 4 Sirolimus(0.8mg/m2);Sirolimus(0.7mg/m2)
4 Percutaneous Administration of Sirolimus in the Treatment of Superficial Complicated Vascular Anomalies: a Randomized Controlled Trial Recruiting NCT04921722 Phase 4 Percutaneous sirolimus;Oral sirolimus
5 Sirolimus Versus Sirolimus Plus Prednisolone for Kaposiform Hemangioendothelioma With Kasabach-Merritt Syndrome Completed NCT03188068 Phase 2 Sirolimus;Prednisolone
6 Efficacy and Safety of Different Concentrations of Sirolimus in the Treatment of Kaposiform Hemangioendothelioma. Recruiting NCT04775173 Phase 2 Sirolimus
7 Different Doses of Sirolimus for the Maintenance Treatment of Kaposiform Hemangioendothelioma: a Randomized Controlled Trial Recruiting NCT05324384 Phase 2 Sirolimus
8 A Randomized Phase 2 Study of Vincristine Versus Sirolimus to Treat High Risk Kaposiform Hemangioendothelioma (KHE). Terminated NCT02110069 Phase 2 Vincristine;Sirolimus
9 A Clinical Study on the Treatment of Kaposiform Hemangioendothelioma (KHE) With Kasabach-Merritt Phenomenon (KMP) by Hormone Shock and Sirolimus Maintenance Not yet recruiting NCT04409691 Phase 1 prednison and Sirolimus;prednison
10 The Effect of Sirolimus on Time-sequentially Scheduled Immunizations During the Treatment of Kaposiform Hemangioendothelioma: a Case-control Study Recruiting NCT05351216
11 Identification of Biomarkers for Patients With Vascular Anomalies Recruiting NCT03001180
12 Lymphatic Anomalies Registry for the Assessment of Outcome Data Recruiting NCT02399527

Search NIH Clinical Center for Kaposiform Hemangioendothelioma

Genetic Tests for Kaposiform Hemangioendothelioma

Genetic tests related to Kaposiform Hemangioendothelioma:

# Genetic test Affiliating Genes
1 Kaposiform Hemangioendothelioma 28

Anatomical Context for Kaposiform Hemangioendothelioma

Organs/tissues related to Kaposiform Hemangioendothelioma:

MalaCards : Endothelial, Lymph Node, Bone, Tongue, Spleen, Skin, Tonsil

Publications for Kaposiform Hemangioendothelioma

Articles related to Kaposiform Hemangioendothelioma:

(show top 50) (show all 363)
# Title Authors PMID Year
1
GNA14 Somatic Mutation Causes Congenital and Sporadic Vascular Tumors by MAPK Activation. 5
27476652 2016
2
Digital subtraction angiography and trans arterial embolization in preventing massive hemorrhage of Kaposiform hemangioendothelioma: A case report. 62
36188091 2022
3
Multifocal Kaposiform Hemangioendothelioma in a Newborn With Confirmatory Histopathology. 62
36193691 2022
4
ALL-481 Infant Cancer in Armenia: Nationwide Survey for the Period of 1995-2021. 62
36163751 2022
5
Bone kaposiform hemangioendothelioma: A rare entity dramatically improved by sirolimus. 62
35138010 2022
6
Aggressive vascular tumor mimicking posttraumatic hematoma: A case report of kaposiform hemangioendothelioma on the nose. 62
35865722 2022
7
Management of pancreatic kaposiform hemangioendothelioma with sirolimus in a pediatric patient: a case report and literature review. 62
36072541 2022
8
How we approach coagulopathy with vascular anomalies. 62
36070211 2022
9
Giant retroperitoneal Kaposiform hemangioendothelioma without Kasabach-Merritt phenomenon: A case report. 62
35961905 2022
10
Rapamycin induces autophagy and apoptosis in Kaposiform hemangioendothelioma primary cells in vitro. 62
35428493 2022
11
Congenital Infantile Fibrosarcoma Involving Pelvic Wall and Thigh Soft Tissues and Placenta, Presenting with Coagulopathy. 62
35834223 2022
12
Clinical features and management of kaposiform hemangioendothelioma and tufted angioma: Similarities and differences. 62
34273457 2022
13
MRI-based radiomics in distinguishing Kaposiform hemangioendothelioma (KHE) and fibro-adipose vascular anomaly (FAVA) in extremities: A preliminary retrospective study. 62
35418319 2022
14
TEMPORARY REMOVAL: PO-51: Kaposiform hemangioendothelioma is associated with platelet functional abnormalities that persist in patients even after complete blood cell count recovery. 62
35643694 2022
15
18F-FDG PET/CT Findings in a Woman With Kaposiform Hemangioendothelioma in the Sacrum. 62
35020652 2022
16
Cellular variant of kaposiform lymphangiomatosis: a report of three cases, expanding the morphologic and molecular genetic spectrum of this rare entity. 62
35202617 2022
17
A rare case of Kasabach Merritt Syndrome presenting with an infantile hemangioma: A case report. 62
35495392 2022
18
Sirolimus plus prednisolone vs sirolimus monotherapy for kaposiform hemangioendothelioma: a randomized clinical trial. 62
35030255 2022
19
[Clinicopathological features of congenital hemangioma: a study of 40 cases]. 62
35249282 2022
20
Kaposiform Hemangioendothelioma of Internal Auditory Canal Presenting in 4-Week-Old Newborn. 62
35024793 2022
21
Kaposiform hemangioendothelioma with fatal income: Kasabach-Merritt phenomenon and hypercalcemia. 62
35198208 2022
22
Neonatal Intestinal Obstruction Due to Kaposiform Hemangioendothelioma of the Jejunum. 62
35187187 2022
23
Kaposiform hemangioendothelioma of the bone in children and adolescents. 62
34606171 2022
24
Stability Testing of Sirolimus in Medium-Chain Triglyceride Oil Using High-Performance Liquid Chromatography. 62
35558349 2022
25
Case report: A rare case of retroperitoneal kaposiform hemangioendothelioma with spinal involvement without abnormal platelet count in 18F-FDG PET/CT. 62
36035391 2022
26
Kaposiform hemangioendothelioma in an unusual site: A report of two cases in children. 62
35074987 2022
27
Indications and Limitations of Sirolimus in the Treatment of Vascular Anomalies-Insights From a Retrospective Case Series. 62
35676905 2022
28
Case report: Experience of a rare case of rebound of the Kasabach-Merritt phenomenon during sirolimus treatment in kaposiform hemangioendothelioma. 62
35990005 2022
29
Comprehensive Therapy for Infant Vascular Tumor Associated With Kasabach-Merritt Phenomenon-Single-Center Primary Experience. 62
35813386 2022
30
Case Report: Congenital Intracranial Kaposiform Hemangioendothelioma Treated With Surgical Resection. 62
35433800 2022
31
Comparison of Effectiveness of Two Different Doses of Propranolol on Kaposiform Hemangioendothelioma. 62
35419320 2022
32
Health-Related Quality of Life in Children With Kaposiform Hemangioendothelioma. 62
35281237 2022
33
A case of sirolimus treatment of kaposiform hemangioendothelioma in the neck. 62
35289458 2022
34
Primary Kaposiform Hemangioendothelioma of the Humerus: A Case Report. 62
35178317 2022
35
Splenic kaposiform hemangioendothelioma presenting as insidious consumptive coagulopathy. 62
34622468 2021
36
Analysis of angiographic characteristics of kaposiform hemangioendothelioma and investigation of the value of transcatheter arterial embolization therapy. 62
35070833 2021
37
Malignant pancreatic tumor other than solid pseudopapillary tumor in pediatric patients: A single-center experience. 62
34918645 2021
38
Kaposiform Hemangioendothelioma of the Oral Cavity: A Rare Tumor with an Unusual Location. 62
33715098 2021
39
A prospective multicenter study of sirolimus for complicated vascular anomalies. 62
34082006 2021
40
Kaposiform Hemangioendothelioma with Kasabach-Merritt Phenomenon. 62
34106442 2021
41
Kaposiform hemangioendothelioma further broadens the phenotype of PIK3CA-related overgrowth spectrum. 62
34402524 2021
42
Cutaneous Vascular Neoplasms of Uncertain Biological Behavior. 62
34827153 2021
43
Kaposiform hemangioendothelioma of leg: An unusual presentation. 62
34975106 2021
44
Management of Refractory Mandibular Kaposiform Hemangioendothelioma with Sirolimus: A Case Report and Review of the Literature. 62
34153244 2021
45
Antiproliferative therapy with sirolimus and propranolol for congenital vascular anomalies in newborns (Case reports). 62
34504551 2021
46
Severe adverse events during sirolimus "off-label" therapy for vascular anomalies. 62
33580918 2021
47
Sirolimus for the treatment of kaposiform hemangioendothelioma: In a trough level-dependent way. 62
33932303 2021
48
Large abdominal purpura of neonatal retroperitoneal kaposiform hemangioendothelioma. 62
34429992 2021
49
Overexpression Prox1 in HemECs resembles Kaposiform hemangioendothelioma and cytotoxicity of sirolimus in vitro. 62
33865602 2021
50
[Clinical features of Kasabach-Merritt syndrome: an analysis of 16 neonates]. 62
34266526 2021

Variations for Kaposiform Hemangioendothelioma

ClinVar genetic disease variations for Kaposiform Hemangioendothelioma:

5
# Gene Name Type Significance ClinVarId dbSNP ID Position
1 GNA14 NM_004297.4(GNA14):c.614A>T (p.Gln205Leu) SNV Likely Pathogenic
548667 rs1554685903 GRCh37: 9:80043932-80043932
GRCh38: 9:77429016-77429016

Cosmic variations for Kaposiform Hemangioendothelioma:

8 (show top 50) (show all 1353)
# Cosmic Mut ID Gene Symbol COSMIC Disease Classification
(Primary site, Site subtype, Primary histology, Histology subtype)
Mutation CDS Mutation AA GRCh38 Location Conf
1 COSM89629521 SF3B1 soft tissue,blood vessel,other,benign c.2014G>T p.A672S 2:197402619-197402619 2
2 COSM87508264 NCOR1 soft tissue,blood vessel,other,benign c.3838G>T p.G1280W 17:16072202-16072202 2
3 COSM101155459 NCOR1 soft tissue,blood vessel,other,benign c.3886G>T p.G1296W 17:16072202-16072202 2
4 COSM101210927 NCOR1 soft tissue,blood vessel,other,benign c.3559G>T p.G1187W 17:16072202-16072202 2
5 COSM144457442 MSH6 soft tissue,blood vessel,other,benign c.2309G>A p.G770D 2:47803462-47803462 2
6 COSM131472690 MSH6 soft tissue,blood vessel,other,benign c.2309G>A p.G770D 2:47803462-47803462 2
7 COSM85779643 MSH6 soft tissue,blood vessel,other,benign c.3215G>A p.G1072D 2:47803462-47803462 2
8 COSM144639336 MSH6 soft tissue,blood vessel,other,benign c.119G>A p.G40D 2:47803462-47803462 2
9 COSM132100831 MSH6 soft tissue,blood vessel,other,benign c.2825G>A p.G942D 2:47803462-47803462 2
10 COSM85400395 MAP2K2 soft tissue,blood vessel,other,benign c.979A>G p.N327D 19:4097284-4097284 2
11 COSM101413162 MAP2K2 soft tissue,blood vessel,other,benign c.688A>G p.N230D 19:4097284-4097284 2
12 COSM106234905 FBXO11 soft tissue,blood vessel,other,benign c.169+4733C>T p.? 2:47803462-47803462 2
13 COSM94290791 XIAP soft tissue,blood vessel,angiosarcoma,NS c.73G>C p.E25Q 23:123885735-123885735 1
14 COSM92181036 XIAP soft tissue,blood vessel,angiosarcoma,NS c.73G>C p.E25Q 23:123885735-123885735 1
15 COSM108084128 XIAP soft tissue,blood vessel,angiosarcoma,NS c.73G>C p.E25Q 23:123885735-123885735 1
16 COSM91383022 WT1 soft tissue,blood vessel,angiosarcoma,NS c.983G>A p.W328* 11:32416508-32416508 1
17 COSM148593299 WT1 soft tissue,blood vessel,angiosarcoma,NS c.983G>A p.W328* 11:32416508-32416508 1
18 COSM100781781 WT1 soft tissue,blood vessel,angiosarcoma,NS c.347G>A p.W116* 11:32416508-32416508 1
19 COSM149739973 WT1 soft tissue,blood vessel,angiosarcoma,NS c.983G>A p.W328* 11:32416508-32416508 1
20 COSM130518667 WT1 soft tissue,blood vessel,angiosarcoma,NS c.314+1069G>A p.? 11:32416508-32416508 1
21 COSM113485009 WT1 soft tissue,blood vessel,angiosarcoma,NS c.983G>A p.W328* 11:32416508-32416508 1
22 COSM111539054 WT1 soft tissue,blood vessel,angiosarcoma,NS c.950+1069G>A p.? 11:32416508-32416508 1
23 COSM147426307 WT1 soft tissue,blood vessel,angiosarcoma,NS c.950+1069G>A p.? 11:32416508-32416508 1
24 COSM149814991 TSC2 soft tissue,blood vessel,angiosarcoma,NS c.1073G>A p.W358* 16:2060767-2060767 1
25 COSM151514404 TSC2 soft tissue,blood vessel,angiosarcoma,NS c.4510C>T p.R1504W 16:2085245-2085245 1
26 COSM150365953 TSC2 soft tissue,blood vessel,angiosarcoma,NS c.1073G>A p.W358* 16:2060767-2060767 1
27 COSM151378978 TSC2 soft tissue,blood vessel,angiosarcoma,NS c.2494C>G p.H832D 16:2074338-2074338 1
28 COSM151755621 TSC2 soft tissue,blood vessel,angiosarcoma,NS c.2494C>G p.H832D 16:2074338-2074338 1
29 COSM150324884 TSC2 soft tissue,blood vessel,angiosarcoma,NS c.1073G>A p.W358* 16:2060767-2060767 1
30 COSM150315618 TSC2 soft tissue,blood vessel,angiosarcoma,NS c.4384C>T p.R1462W 16:2085245-2085245 1
31 COSM102634843 TSC2 soft tissue,blood vessel,angiosarcoma,NS c.2494C>G p.H832D 16:2074338-2074338 1
32 COSM148983289 TSC2 soft tissue,blood vessel,angiosarcoma,NS c.4387C>T p.R1463W 16:2085245-2085245 1
33 COSM101196039 TSC2 soft tissue,blood vessel,angiosarcoma,NS c.2347C>G p.H783D 16:2074338-2074338 1
34 COSM136629025 TSC2 soft tissue,blood vessel,angiosarcoma,NS c.1106G>A p.W369* 16:2060767-2060767 1
35 COSM87041278 TSC2 soft tissue,blood vessel,angiosarcoma,NS c.1073G>A p.W358* 16:2060767-2060767 1
36 COSM148996186 TSC2 soft tissue,blood vessel,angiosarcoma,NS c.2494C>G p.H832D 16:2074338-2074338 1
37 COSM150586941 TSC2 soft tissue,blood vessel,angiosarcoma,NS c.2494C>G p.H832D 16:2074338-2074338 1
38 COSM147712334 TSC2 soft tissue,blood vessel,angiosarcoma,NS c.2494C>G p.H832D 16:2074338-2074338 1
39 COSM110114858 TSC2 soft tissue,blood vessel,angiosarcoma,NS c.962G>A p.W321* 16:2060767-2060767 1
40 COSM136619132 TSC2 soft tissue,blood vessel,angiosarcoma,NS c.4417C>T p.R1473W 16:2085245-2085245 1
41 COSM90415849 TSC2 soft tissue,blood vessel,angiosarcoma,NS c.1073G>A p.W358* 16:2060767-2060767 1
42 COSM151518304 TSC2 soft tissue,blood vessel,angiosarcoma,NS c.1073G>A p.W358* 16:2060767-2060767 1
43 COSM110120269 TSC2 soft tissue,blood vessel,angiosarcoma,NS c.2383C>G p.H795D 16:2074338-2074338 1
44 COSM149803740 TSC2 soft tissue,blood vessel,angiosarcoma,NS c.4453C>T p.R1485W 16:2085245-2085245 1
45 COSM150369517 TSC2 soft tissue,blood vessel,angiosarcoma,NS c.2494C>G p.H832D 16:2074338-2074338 1
46 COSM150584116 TSC2 soft tissue,blood vessel,angiosarcoma,NS c.1073G>A p.W358* 16:2060767-2060767 1
47 COSM110105462 TSC2 soft tissue,blood vessel,angiosarcoma,NS c.4276C>T p.R1426W 16:2085245-2085245 1
48 COSM90421077 TSC2 soft tissue,blood vessel,angiosarcoma,NS c.2494C>G p.H832D 16:2074338-2074338 1
49 COSM151371641 TSC2 soft tissue,blood vessel,angiosarcoma,NS c.4579C>T p.R1527W 16:2085245-2085245 1
50 COSM151519993 TSC2 soft tissue,blood vessel,angiosarcoma,NS c.2494C>G p.H832D 16:2074338-2074338 1

Expression for Kaposiform Hemangioendothelioma

Search GEO for disease gene expression data for Kaposiform Hemangioendothelioma.

Pathways for Kaposiform Hemangioendothelioma

GO Terms for Kaposiform Hemangioendothelioma

Sources for Kaposiform Hemangioendothelioma

2 CDC
6 CNVD
8 Cosmic
9 dbSNP
10 DGIdb
16 EFO
17 ExPASy
18 FMA
19 GARD
27 GO
28 GTR
29 HMDB
30 HPO
31 ICD10
32 ICD10 via Orphanet
33 ICD11
34 ICD9CM
35 IUPHAR
36 LifeMap
38 LOVD
40 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
52 NINDS
53 Novoseek
55 ODiseA
56 OMIM via Orphanet
57 OMIM® (Updated 24-Oct-2022)
61 PubChem
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....